From: Development of the “Treatment beliefs in knee and hip OsteoArthritis (TOA)” questionnaire
Demographic characteristics | |
Age (years), mean (SD) | 62.8 (12.3) |
Gender (female), n (%) | 217 (63.1) |
Married or cohabiting, n (%) | 273 (79.4) |
Currently employed, n (%)b | 145 (44.1) |
Education level, n (%)c | |
Low | 62 (18.0) |
Middle | 175 (50.9) |
High | 107 (31.1) |
Clinical characteristics | |
Body Mass Index (BMI) (kg/m2), n(%) | |
Normal weight (BMI <25) | 106 (31.0) |
Overweight (BMI 25–30) | 146 (42.7) |
Obese (BMI > 30) | 90 (26.3) |
Duration of OA symptoms (years), mean (SD)b | 11.1 (9.8) |
Affected joint(s), n (%) | |
Hip | 82 (24) |
Knee | 169 (49.5) |
Hip and knee | 91 (26.5) |
Comorbidities, n(%)d | |
No comorbidities | 141 (40.8) |
High blood pressure | 97 (28.0) |
Heart disease | 39 (11.2) |
Diabetes | 27 (7.8) |
Lung disease | 28 (8) |
Other | 42 (12) |
Previous or current treatments for OA, n (%)d | |
Pain medication | 291 (85.3) |
Physiotherapy | 234 (68.6) |
Injections | 133 (39.0) |
Surgery | 112 (32.8) |
WOMACe (Likert scale 0–4), unstandardized mean (SD), theoretical range | |
Painb | 10.0 (4.5), 0–20 |
Stiffness | 4.5 (2.0), 0–8 |
Functioning | 32.4 (14.8), 0–68 |
Total (sum score)b | 46.7 (20.0), 0–96 |